Danish/Swedish Study Appears to Validate Potentially Bad Batches of Pfizer-BioNTech mRNA Vaccine (BNT162b2), Linked to SAEs

A wide variation in the risk of side effects after COVID-19 vaccination was found from another previous study in Denmark. For example, some of the people who received Pfizer/BioNTech&rsquo;s mRNA-based COVID-19 (BNT162b2) vaccine especially earlier on had a significantly higher risk of reported side effects than others. What&rsquo;s behind such an observation?&nbsp;Enter the study led by physician-scientist and author Vibeke Manniche, MD, PhD, and colleagues including prominent University of Copenhagen cardiologist and professor Peter Riis Hansen, MD DMSc PhD. The four collaborators sought to confirm previous findings (Schmeling et al., 2023) in an independent data set by analyzing publicly available records of suspected adverse events related to BNT162b2/Comirnaty from the Swedish Medical Products Agency (57,000 records spanning 3 years of reports).
The Study